Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Gritstone Says Omicron Mutations Minimally Impact T-Cell Epitope Sequences In Its COVID-19 Vaccines
November 29, 2021
Tickers
GRTS
From Benzinga
Chembio Diagnostics' DPP COVID-19 Antigen Test Approved In South Africa
November 29, 2021
Tickers
CEMI
From Benzinga
Adagio Says Its COVID-19 Antibody Likely To Retain Activity Against Omicron Variant
November 29, 2021
Tickers
ADGI
From Benzinga
Why Are NRx Pharma's Shares Soaring Premarket?
November 29, 2021
From Benzinga
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant
November 29, 2021
From Benzinga
Applied DNA Stock Surges On Launch Plans For Linea 2.0 COVID-19 Assay For Omicron Variant
November 29, 2021
Tickers
APDN
From Benzinga
Thermo Fisher Says Its COVID-19 Tests Can Detect Omicron Variant
November 29, 2021
Tickers
TMO
From Benzinga
What We Know About The New COVID-19 Variant Spreading In South Africa
November 26, 2021
From Benzinga
Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%
November 26, 2021
Tickers
MRK
From Benzinga
From Benzinga
Pfizer Sues Former Employee For Stealing Confidential Info On Its Megablockbuster COVID-19 Vaccine
November 24, 2021
From Benzinga
Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada
November 24, 2021
From Benzinga
Ocugen-Partnered Bharat Biotech's COVID-19 Shot Shows 50% Effectiveness In Small Study In India
November 24, 2021
Tickers
OCGN
From Benzinga
FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate
November 24, 2021
From Benzinga
Why Are Valneva Shares Trading Higher Today?
November 23, 2021
From Benzinga
EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks'
November 22, 2021
From Benzinga
Pfizer-BioNTech's COVID-19 Vaccine Shows 100% Effectiveness In Long Term Analysis In Adolescents
November 22, 2021
From Benzinga
EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness
November 19, 2021
Tickers
MRK
From Benzinga
From Benzinga
CureVac's COVID-19 Vax Shows Comparable Antibody Levels To Pfizer/BioNTech's Shot In Animal Study
November 18, 2021
From Benzinga
AstraZeneca's COVID-19 Antibody Shows 83% Protection Over Six Months
November 18, 2021
From Benzinga
Novavax Shares Are Rising On Incremental COVID-19 Vaccine Related News
November 17, 2021
Tickers
NVAX
From Benzinga
US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B
November 17, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.